Vaccine Against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer

Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-09-0194
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Colonic Microbiota Is Associated With Inflammation and Host Epigenomic Alterations in Inflammatory Bowel Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

IRW and IQW Reduce Colitis-Associated Cancer Risk by Alleviating DSS-Induced Colonic Inflammation

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Cancer and Reconstructive Surgery in Inflammatory Bowel Disease

Linköping University Medical Dissertations
2019English

Thrombin Drives Tumorigenesis in Colitis-Associated Colon Cancer

Cancer Research
Cancer ResearchOncology
2014English

Intestinal Inflammation and Inflammatory Bowel Disease

2016English

Targeting of the MUC1-C Oncoprotein in Colitis-Associated Colorectal Cancer

2014English

Therapeutic MUC1-Based Cancer Vaccine Expressed in Flagella-Efficacy in an Aggressive Model of Breast Cancer

World Journal of Vaccines
2012English

Smad7 Expression in T Cells Prevents Colitis-Associated Cancer

Cancer Research
Cancer ResearchOncology
2011English

Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice

Gastroenterology
HepatologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy